These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels. Crawford DC; Restrepo NA; Diggins KE; Farber-Eger E; Wells QS BMC Med Genomics; 2018 Sep; 11(Suppl 3):66. PubMed ID: 30255797 [TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study. Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083 [TBL] [Abstract][Full Text] [Related]
17. Aerobic exercise reduces triglycerides by targeting apolipoprotein C3 in patients with coronary heart disease. Wang Y; Shen L; Xu D Clin Cardiol; 2019 Jan; 42(1):56-61. PubMed ID: 30511426 [TBL] [Abstract][Full Text] [Related]
18. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes. Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160 [TBL] [Abstract][Full Text] [Related]
19. Variable effects of the APOC3-482C > T variant on insulin, glucose and triglyceride concentrations in different ethnic groups. Waterworth DM; Talmud PJ; Humphries SE; Wicks PD; Sagnella GA; Strazzullo P; Alberti KG; Cook DG; Cappuccio FP Diabetologia; 2001 Feb; 44(2):245-8. PubMed ID: 11270684 [TBL] [Abstract][Full Text] [Related]